The oncoprotein TBX3 is controlling severity in experimental arthritisShow others and affiliations
2019 (English)In: Arthritis Research & Therapy , E-ISSN 1478-6362, Vol. 21, no 1, article id 16Article in journal (Refereed) Published
Abstract [en]
Background: Development of autoimmune diseases is the result of a complex interplay between hereditary and environmental factors, with multiple genes contributing to the pathogenesis in human disease as well as in experimental models for disease. The T-box protein 3 is a transcriptional repressor essential during early embryonic development, in the formation of bone and additional organ systems, and in tumorigenesis.
Methods: With the aim to find novel genes important for autoimmune inflammation, we have performed genetic studies of collagen-induced arthritis, a mouse experimental model for Rheumatoid Arthritis.
Results: We show that a small genetic fragment on mouse chromosome 5, including Tbx3 and three additional protein-coding genes, is linked to severe arthritis and high titers of anti-collagen antibodies. Gene expression studies have revealed differential expression of Tbx3 in B-cells, where low expression was accompanied by a higher B-cell response upon B-cell receptor stimulation in vitro. Furthermore, we show that serum TBX3 levels rise concomitantly with increasing severity of CIA.
Conclusions: From these results, we suggest that TBX3 is a novel factor important for the regulation of gene transcription in the immune system and that genetic polymorphisms, resulting in lower expression of Tbx3, are contributing to a more severe form of collagen-induced arthritis and high titers of autoantibodies. We also propose TBX3 as a putative diagnostic biomarker for rheumatoid arthritis.
Place, publisher, year, edition, pages
London: BioMed Central, 2019. Vol. 21, no 1, article id 16
Keywords [en]
Collagen-induced arthritis, transcriptional regulation, TBX3, TBX5, biomarker, Eae39r
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:hh:diva-38630DOI: 10.1186/s13075-018-1797-3ISI: 000455453800003PubMedID: 30630509Scopus ID: 2-s2.0-85059817411OAI: oai:DiVA.org:hh-38630DiVA, id: diva2:1271294
Note
Funding: The Danish Rheumatism Association, The AP Møller Research grant for Medical Science and The Oticon foundation
2018-12-172018-12-172025-10-01Bibliographically approved